EXTON, Pa.--(BUSINESS WIRE)-- #CRO--Melior Discovery, Inc. (Melior) announced today that it has been selected as a top-20 CRO in the most recent edition of Pharma Tech Outlook magazine. This cover story article recognized Melior's approach towards providing bespoke solutions in the preclinical in vivo pharmacology space and its pioneering achievements in phenotypic screening vis-à-vis its theraTRACE® platform. "I am very proud of the acknowledgment provided by the Pharma Tech editors on the strides th